Thrombomodulin (TM), in addition to its significance in the protein C anticoagulant pathway and cardiovascular diseases, has recently been shown to play important roles in normal embryonic development, several inflammatory conditions, as well as in tumor biology and in the pathogenesis of chronic radiation toxicity. We cloned and sequenced the cDNA encoding the complete TM protein from the Sprague-Dawley rat. The cDNA sequence consisted of a 78-bp 5' non-coding region and a 1731-bp open reading frame encoding 577 amino acids. Comparison of the deduced amino acid sequences showed Sprague-Dawley rat TM to be 87% homologous with mouse and 70.3% with human TM. In addition to the previously described highly conserved region in the lectin-like domain, another region was found which possessed significant homology among the species and may be involved in regulating cell surface expression of TM. Primers and fluorogenic probe for 5' exonuclease-based real time RT-PCR detection (TaqMan™ PCR) were constructed based on the cDNA sequence information and used to determine steady-state TM mRNA levels in lung, intestine, kidney, brain, and liver. The highest TM mRNA levels were found in lung and the lowest in liver. Immunohistochemistry confirmed that TM was mainly localized on the endothelium of blood vessels and lymphatics. The alveolar capillaries of lung showed the strongest immunoreactivity, whereas the endothelium of hepatic sinusoids and cerebral cortex were virtually negative.
Thrombomodulin (TM), an endothelial cell surface tial for normal embryonic development, and its absence glycoprotein, is a key regulator of the protein C antico-causes embryonic lethality in mice before development of agulant pathway and plays a pivotal role in maintaining a functional cardiovascular system and expression of the coagulation-anticoagulation homeostasis in vivo. 1 Recent thrombin gene. 10 accumulating evidence suggests that TM has several imThe complete cDNAs encoding the mouse and huportant functions beyond anticoagulation. In addition man TM proteins have been previously cloned and to its recognized significance in cardiovascular disease, sequenced, n~1 3 and a partial Norway TM cDNA sedata from our laboratory and others show that TM is a quence has been posted on the GenBank database. Bevaluable tumor marker, 2 ' 3 and that it may play a central cause of the common use of the rat in many experimental role in the mechanisms of chronicity in normal tissue ra-models, and because only 71% of the TM cDNA sequence diation injury, 4 ' 5 inflammatory bowel diseases, 6 and cer-in this species was known, we cloned and sequenced the tain vascular and autoimmune disorders. 7~9 TM is essen-entire coding area and partial 5' end flanking region of Lung tissue was used as the source for RNA isolation because of its high thrombomodulin content. 11 Total RNA was extracted with Trizol® reagent (Gibco BRL, Grand Island, NY). The 5' end oligonucleotide primer was designed according to a homologous region 5'-fianking the coding sequence of mouse and human TM. The 3' end primer was designed according to a homologous 3'-flanking region of mouse, human and bovine TM.
11 " 14 The sequence of the 5' end primer (forward) was 5' CCT GAA CAG CAT GCT TGG G 3' (bp 69-87 in Fig. 1 ) and that of the 3' end primer (reverse) was 5' CTC AGA ACT TCT GCA GCG TCC G 3' (bp 1813-1772) (synthesized by Life Technologies, Grand Island, NY). Reverse transcription-polymerase chain reaction (RT-PCR) was performed using GeneAmp PCR System 9600 (Perkin-Elmer Cetus, Foster City, CA). PCR amplified cDNA fragments were a pure single band and corresponded to the predicted size of TM (1.8 kb) upon analysis by agarose gel electrophoresis. The identity of this product was confirmed by Southern blot analysis using a radiolabeled mouse TM cDNA probe (gift of Dr. Steve R. Lentz, University of Iowa, Iowa City, IA).
Two PCR amplification products from independent reactions performed on lung tissue DNA samples from two different animals were resolved on 1% agarose gel by electrophoresis. The bands were excised, DNA was recovered by Wizard® PCR Preps DNA Purification System (Promega Corp., Madison, WI), and cloned into pGEM®-T easy vector (Promega). The cloned vectors were transformed into JM109 High Competent Cells, and the cells were plated on LB/ampicillin/IPTG/XGal plates. After incubation overnight at 37°C, white colonies were picked and grown in Luria Bertani medium (LB broth). Plasmid DNA was purified and subjected to restriction enzyme analysis. The inserts were identified to be about 1.8 kb in 1% agarose gel. Both strands of each of the two inserts were sequenced by the dideoxy nucleotide chain termination method 6 using ABI PRISM dye terminator cycle sequencing ready reaction kit and model 377 Automated DNA Sequencing System (PE Applied Biosystems, Perkin-Elmer, Foster City, CA). Computer analysis of sequence data was performed using the GCG Sequence Analysis Software Package (Genetics Computer Group, Inc., Madison, Wisconsin).
DNA sequence analysis showed that Sprague-Dawley rat TM cDNA contains a 5' end untranslated region of 78 bases, followed by 1731 bases encoding 577 amino acids. The complete open reading frame (ORF) starts from ATG at nucleotides 79-81 and ends at TGA of nucleotides 1810-1812 (Fig. 1) .
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Comparison with Deduced Mouse and Human Amino Acid Sequences
The predicted Sprague-Dawley rat TM amino acid sequence was compared with all entries in the GenBank database that contained a complete coding sequence, human (575 amino acids) and mouse (577 amino acids) (Fig. 2) . The Sprague-Dawley rat TM was 70.3% homologous with human and 87.0% homologous with mouse TM. The predicted Sprague-Dawley rat TM protein, similar to mouse and human TM, 11 ' 12 contains a hydrophobic leader sequence (fimino acids 1-18) which is thought to be a signal peptide, 12 a lectin-like domain, a region of epidermal growth factor (EGF)-like repeats, a serine/threonine-rich region that is the most heterogeneous region among species, a transmembrane domain, and a cytoplasmic tail. Dittman et al. 11 previously compared the predicted amino acids sequence of human TM with a partial sequence of mouse TM and found that the lectin-like domain contains a highly conserved region (amino acids 102-125), in which 22 of 23 amino acids are identical. When comparing the entire coding region among human, mouse, and Sprague-Dawley rat TM, we found an additional highly conserved region (amino acids 57-74) within the lectin-like domain, in which 18 amino acids were completely identical among the three species. These highly conserved regions might be important for TM localization or activity, although their functional significance is still not known. Recent evidence suggests that the lectin-like domain of human TM is involved in the regulation of cell surface expression of TM and in the control of intracellular and extracellular accumulation of thrombin by mediating its constitutive endocytic routing from the cell surface membrane. 15 The transmembrane domain is also highly conserved among species, in that 20 of 23 amino acids are identical and the remaining 3 are conservative substitutions.
Comparison with a partial Norway rat cDNA sequence posted on the GenBank database (accession number U90121, 461 amino acid overlap) revealed 99.5% homology with our complete sequence. There were nine different amino acids in the overlap region between SpragueDawley rat (577 amino acids) and Norway rat TM (461 amino acids): the 119th-123rd and 572nd amino acid of the Sprague-Dawley rat TM, although identical to mouse and human TM, were different from Norway rat TM. The Norway rat amino acid sequence included an additional amino acid (176th), which was not found in the Sprague-Dawley rat, mouse, or human cDNA. One additional amino acid of the Sprague-Dawley rat TM, 584th, differed from the Norway rat TM, but was identical to mouse and bovine TM. Thus, it is unlikely that these differences are due to errors in sequencing of the Sprague-Dawley rat cDNA or to errors arising from our PCR amplification. A single amino acid (287th) was different in all four species.
Assessment of TM Gene Expression in Rat Tissues Using TaqMan™ PCR
The TM cDNA sequence data were used to design a fluorogenic probe and oligonucleotide primers for 5' exonuclease-based real time PCR (TaqMan™ PCR) using the ABI Prism 7700 Sequence Detection System (PE Applied Biosystems) and reagents, and kits from PerkinElmer (Foster City, CA).
A 22-base oligonucleotide probe, 6FAM-CCT GCG CAA GAA GCA GGG CAC T-TAMRA, (bp 1698-1719) was designed according to the rat thrombomodulin sequence cloned and sequenced in the present study, and Thrombomodulin Gene of Sprague-Dawley Rat [Vol. 6, synthesized and labeled by Perkin-Elmer. The probe contained FAM (6-carboxy-fluorescein) as the fluorescent reporter dye covalently linked to the 5' end. The quencher dye TAMRA (6-carboxytetramethylrhodamine) was covalently linked to the 3' end. The forward and reverse primer sequences were 5' GCT TTT GGC GCT TCT TTG TC 3' (bp 1677-1696) and 5' CTC CTT GGC TGA AGA GGT ACA CTT 3' (bp 1764-1741), respectively (synthesized by Life Technologies).
TM cDNA plasmid was linearized with Spe I and incubated with T7 RNA polymerase. The Riboprobe Transcription System (Promega) was used for in vitro RNA synthesis. The 1877-base cRNA was used to construct the standard curve.
Eight 40-day-old male Sprague-Dawley rats (Harlan, Indianapolis, IN) were euthanized. Intestine, liver, lung, kidney and brain were procured and total RNA was extracted with TRI-Reagent solution (Molecular Research Center, Cincinnati, OH). A total volume of 50 /xl contained 1 x TaqMan buffer A, 5 mM MgCl 2 , 300 (M. of each ATP, GTP, CTP and UTP, 400 nM of each forward and reverse primer, 100 nM probe, 20 unit RNAse inhibitor, 12.5 unit MuLV, 12.5 unit AmpliTaq Gold, 50 ng of total RNA. Reverse transcription was carried out at 42°C for 30 min, followed by 10 min at 95°C to activate the TaqMan™ DNA polymerase. Thirty-five cycles of amplification were carried out by denaturing at 95°C for 15 sec, and annealing at 60°C for 1 min. All samples were run in duplicate in a single 96-well plate, including three controls without the RNA template.
Lung contained the highest copy number of TM mRN A (4.2 x 10 6 copies per 50 ng mRNA), followed by kidney (1. (Fig. 3) . The TM mRNA levels in each of the five organs were distributed normally, thus validating the TaqMan™ PCR assay with this primer-probe combination (Fig. 4) . The coefficients of variation were 0.13 for lung, 0.17 for brain, 0.25 for liver, 0.27 for kidney, and 0.35 for intestine.
Localization of TM in Rat Tissues Using Immunohistochemical Technique
Samples of lung, kidney, liver, intestine, and brain from the same 8 rats that were used for TaqMan™ PCR, were fixed in Methanol Carnoy's solution and processed for immunohistochemistry. Paraffin-embedded specimens were cut at 4-5 ^m, deparaffinized, and treated with 1% (v/v) hydrogen peroxide. Nonspecific protein binding was blocked by incubation in 10% normal goat serum. The sections were incubated for 2 hr with rabbit anti-TM antibody at 1:200 dilution (gift of Dr. Philip W. Majerus, Washington University School of Medicine, St. Louis, MO). The secondary biotinylated goat anti-rabbit antibody was applied for 30 min at 1:400 dilution, and then incubated with streptavidin-biotin-peroxidase com- Comparison of our mRNA data and immunohistochemical observations demonstrated similar patterns of expression, in that lung expressed the highest amount of TM and liver the lowest. Pulmonary TM immunoreactivity was localized to endothelial cells in alveolar capillaries and venules, with small amounts present in larger arteries and veins. In the kidney, most of the immunoreactivity was found in the glomeruli In the liver, endothelium of hepatic arteries and portal veins in the portal triades stained positive, whereas, hepatic sinusoids and central veins exhibited little or no immunoreactivity. The endothelium of vessels in the cerebral cortex did not show TM immunoreactivity, whereas, endothelial cells of some meningeal and sub-meningeal blood vessels were positive. These data are in agreement with Ishii et al. 18 who found TM to be absent from human brain by radioimmunoassay. In contrast, Tran et al. 19 ' 20 found significant amounts of TM protein and mRNA in bovine brain cortex by competitive PCR and RT-PCR. Considering our immunohistochemical results, the TM mRNA detected in rat cortical tissue by TaqMan™ PCR is most likely from the pia mater and the vessels underlying the pia.
The differences in TM expression among organs do not appear to be due only to differences in the relative number of endothelial cells per organ, but may also reflect differences among various types of endothelium. For example, Ford et al. suggested that organs in which capillaries have continuous endothelium express higher levels of TM than organs with fenestrated capillaries. 21 On the other hand, the absence of TM from cerebral vessels is not in agreement with this theory. It has been suggested that the lack of TM in cerebral endothelium is an organ-specific characteristic of brain vasculature, along with tight junctions, lack of vesicles, and high concentration of certain enzymes. 18 
